Judit Castillo‐Armengol

458 total citations
7 papers, 248 citations indexed

About

Judit Castillo‐Armengol is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Judit Castillo‐Armengol has authored 7 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Judit Castillo‐Armengol's work include Pancreatic function and diabetes (3 papers), Adipose Tissue and Metabolism (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Judit Castillo‐Armengol is often cited by papers focused on Pancreatic function and diabetes (3 papers), Adipose Tissue and Metabolism (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Judit Castillo‐Armengol collaborates with scholars based in Switzerland, France and United Kingdom. Judit Castillo‐Armengol's co-authors include Isabel C. López‐Mejía, Lluís Fajas, Sandrine Lagarrigue, Lianjun Zhang, Laia Martínez-Carreres, Albert Giralt, Meritxell Orpinell, Pierre‐Damien Denechaud, Benoı̂t Viollet and Caterina Collodet and has published in prestigious journals such as Molecular Cell, Cancer Research and Diabetologia.

In The Last Decade

Judit Castillo‐Armengol

7 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judit Castillo‐Armengol Switzerland 6 134 74 48 48 46 7 248
Montserrat Romero Spain 10 164 1.2× 68 0.9× 41 0.9× 47 1.0× 68 1.5× 15 295
Jiayi Tan China 7 112 0.8× 132 1.8× 63 1.3× 51 1.1× 96 2.1× 18 343
Eva Röder Switzerland 3 115 0.9× 82 1.1× 20 0.4× 45 0.9× 70 1.5× 4 215
Enbo Zhu China 7 103 0.8× 78 1.1× 51 1.1× 36 0.8× 45 1.0× 10 261
Aman Rathore United States 4 139 1.0× 127 1.7× 39 0.8× 130 2.7× 37 0.8× 5 328
Sissel E. Dyrstad Norway 7 182 1.4× 51 0.7× 55 1.1× 82 1.7× 30 0.7× 8 290
Evan H. Nicklas United States 5 185 1.4× 55 0.7× 25 0.5× 41 0.9× 115 2.5× 7 323
Mikiko Ohno Japan 8 109 0.8× 64 0.9× 79 1.6× 29 0.6× 34 0.7× 22 266
Bibian García Spain 7 193 1.4× 64 0.9× 50 1.0× 51 1.1× 39 0.8× 10 357

Countries citing papers authored by Judit Castillo‐Armengol

Since Specialization
Citations

This map shows the geographic impact of Judit Castillo‐Armengol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Castillo‐Armengol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Castillo‐Armengol more than expected).

Fields of papers citing papers by Judit Castillo‐Armengol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Castillo‐Armengol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Castillo‐Armengol. The network helps show where Judit Castillo‐Armengol may publish in the future.

Co-authorship network of co-authors of Judit Castillo‐Armengol

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Castillo‐Armengol. A scholar is included among the top collaborators of Judit Castillo‐Armengol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Castillo‐Armengol. Judit Castillo‐Armengol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Castillo‐Armengol, Judit, Flavia Marzetta, Christian Fledelius, et al.. (2023). Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia. Diabetologia. 67(2). 371–391. 5 indexed citations
2.
Picard, Alexandre, Xavier Berney, Judit Castillo‐Armengol, et al.. (2022). Hypothalamic Irak4 is a genetically controlled regulator of hypoglycemia-induced glucagon secretion. Molecular Metabolism. 61. 101479–101479. 6 indexed citations
3.
Ji, Honglei, Judit Castillo‐Armengol, René Dreos, et al.. (2020). CDK7 Mediates the Beta-Adrenergic Signaling in Thermogenic Brown and White Adipose Tissues. iScience. 23(6). 101163–101163. 10 indexed citations
4.
Martínez-Carreres, Laia, Julien Puyal, Lucía C. Leal-Esteban, et al.. (2019). CDK4 Regulates Lysosomal Function and mTORC1 Activation to Promote Cancer Cell Survival. Cancer Research. 79(20). 5245–5259. 34 indexed citations
5.
Castillo‐Armengol, Judit, Lluís Fajas, & Isabel C. López‐Mejía. (2019). Inter‐organ communication: a gatekeeper for metabolic health. EMBO Reports. 20(9). e47903–e47903. 106 indexed citations
6.
López‐Mejía, Isabel C., Sandrine Lagarrigue, Albert Giralt, et al.. (2017). CDK4 Phosphorylates AMPKα2 to Inhibit Its Activity and Repress Fatty Acid Oxidation. Molecular Cell. 68(2). 336–349.e6. 55 indexed citations
7.
López‐Mejía, Isabel C., Judit Castillo‐Armengol, Sandrine Lagarrigue, & Lluís Fajas. (2017). Role of cell cycle regulators in adipose tissue and whole body energy homeostasis. Cellular and Molecular Life Sciences. 75(6). 975–987. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026